Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
respiratory treatment
Biotech
Mesoblast told to try again by FDA on Novartis-backed COVID drug
Mesoblast has been put on blast by the FDA yet again after the agency requested another trial for its failed, Novartis-backed COVID-19 drug.
Kyle LaHucik
Sep 1, 2021 11:05am
FDA dishes out Class I label to Philips' ventilator recall
Jul 23, 2021 9:47am
IQVIA and BREATHE team up on respiratory conditions, long COVID
Jul 21, 2021 3:17pm
NRx hopes 'guided missile' COVID-19 antiviral will get FDA nod
Jun 2, 2021 9:45am
Pieris Pharma nabs $20M upfront in Genentech collaboration
May 25, 2021 10:55am
Orgenesis inks Koligo buyout to gain COVID-19 cell therapy
Sep 29, 2020 8:35am
